ZHEJIANG WECOME PHARMACEUTICAL COMPANY LIMITED |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 17.76 CNY | +1.49% |
|
-2.15% | -30.00% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
Zhejiang Wecome Pharmaceutical Co Ltd is a China-based company mainly engaged in the research, development, production and sales of modern Chinese medicine and western medicine. The Company's main products include Yinhuang dripping pills, motherwort soft capsules, motherwort dispersible tablets, Guci capsules, Fengliao Changweikang dispersible tablets, ginseng Jianpi tablets and other Chinese patent medicines, as well as western medicines such as roxithromycin soft capsules. Its production dosage forms cover hard capsules, tablets, granules, soft capsules, and pills. The Company mainly conducts its businesses in the China market.
Sector
Pharmaceuticals
Calendar
26/08/2024
- Q2 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -30.00% | 355M | |
| +37.74% | 723B | |
| +34.61% | 595B | |
| -2.07% | 369B | |
| +20.25% | 332B | |
| +2.99% | 282B | |
| +17.19% | 244B | |
| +10.03% | 208B | |
| -4.13% | 205B | |
| +7.43% | 166B |
- Stock Market
- Equities
- 300878 Stock
- News Zhejiang Wecome Pharmaceutical Company Limited
- Zhejiang Wecome Pharma to Issue $95 Million Convertible Bonds
